Vical Company Profile (NASDAQ:VICL)

Analyst Ratings

Consensus Ratings for Vical (NASDAQ:VICL) (?)
Ratings Breakdown: 1 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: N/A

Analysts' Ratings History for Vical (NASDAQ:VICL)
Show:
DateFirmActionRatingPrice TargetActions
7/19/2016HC WainwrightReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/23/2015Roth CapitalDowngradeBuy -> Neutral$4.65 -> $1.65View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/25/2014 forward)

Earnings

Earnings History for Vical (NASDAQ:VICL)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/28/2016        
5/9/2016Q116($0.04)($0.03)$6.88 million$4.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/14/2016Q415($0.02)($0.03)$4.82 million$6.81 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/30/2015Q215($0.06)($0.03)$3.80 million$4.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/8/2015Q115($0.05)($0.04)$2.50 million$4.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/26/2015Q414($0.05)($0.05)$4.82 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/30/2014Q314($0.05)($0.05)$2.50 million$3.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/31/2014Q214($0.05)($0.05)$1.90 million$4.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/1/2014Q114($0.05)($0.04)$1.60 million$2.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/11/2014Q413($0.09)($0.03)$1.54 million$3.15 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/31/2013Q313($0.10)($0.11)$1.82 million$1.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/1/2013Q2 2013($0.11)($0.11)$1.70 million$3.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/9/2013Q1 2013($0.11)($0.11)$2.02 million$1.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/6/2013Q4 2012($0.10)($0.09)$1.64 million$2.32 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/7/2012Q312($0.09)($0.09)$1.47 million$2.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/1/2012($0.09)($0.09)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/1/2011$0.11$0.22ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/3/2011($0.12)($0.12)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Vical (NASDAQ:VICL)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Vical (NASDAQ:VICL)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Vical (NASDAQ:VICL)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
7/11/2016Lawrence Russell SmithVPSell54$4.46$240.84View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/14/2016Robert C MertonDirectorBuy9,000$4.34$39,060.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/9/2016Vijay B SamantCEOBuy15,700$4.72$74,104.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/6/2016R Gordon DouglasDirectorBuy10,078$4.41$44,443.98View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/3/2016Gary A LyonsDirectorBuy7,078$4.39$31,072.42View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/15/2016Lawrence Russell SmithVPSell8,750$0.41$3,587.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/3/2016Vijay B SamantCEOSell37,500$0.36$13,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/19/2016Anthony Alan RamosCAOSell7,500$0.33$2,475.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/25/2016Anthony Alan RamosCAOSell193$0.35$67.55View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/12/2016Vijay B. SamantCEOSell59,737$0.35$20,907.95View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/11/2016Lawrence Russell SmithVPSell974$0.36$350.64View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/11/2016Vijay B. SamantCEOSell48,535$0.35$16,987.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/7/2016Vijay B SamantCEOSell75,000$0.36$27,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/12/2015Lawrence Russell SmithVPSell974$0.43$418.82View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/12/2015Vijay B SamantCEOSell4,738$0.41$1,942.58View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/13/2015Igor BilinskySVPSell1,258$0.70$880.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/13/2015Lawrence Russell SmithVPSell974$0.70$681.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/13/2015Vijay B SamantCEOSell4,737$0.70$3,315.90View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/13/2015Igor BilinskySVPSell1,257$0.93$1,169.01View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/13/2015Vijay B SamantCEOSell4,738$0.93$4,406.34View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/30/2015Vijay B SamantCEOSell55,000$0.91$50,050.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/13/2015Vijay B SamantCEOSell4,737$1.12$5,305.44View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/12/2015Igor BilinskySVPSell1,335$1.16$1,548.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/12/2015Lawrence Russell SmithVPSell1,912$1.16$2,217.92View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/13/2014Igor BilinskySVPSell1,335$1.08$1,441.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/13/2014Lawrence Russell SmithVPSell1,912$1.08$2,064.96View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/13/2014Vijay B SamantCEOSell4,738$1.13$5,353.94View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/26/2014Anthony Alan RamosCAOSell12,500$1.25$15,625.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/14/2014Vijay B SamantCEOSell4,737$1.17$5,542.29View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/11/2014Lawrence Russell SmithVPSell1,912$1.16$2,217.92View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/14/2014Vijay SamantCEOSell4,738$1.16$5,496.08View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/11/2014Lawrence Russell SmithVPSell1,912$1.21$2,313.52View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/10/2014Anthony Alan RamosCAOBuy70,000$1.42$99,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/10/2014Igor BilinskyVPBuy90,000$1.42$127,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/10/2014Vijay SamantCEOBuy330,000$1.42$468,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/12/2013James R SingerMajor ShareholderSell200,000$1.29$258,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/11/2013James R SingerMajor ShareholderSell300,000$1.30$390,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/10/2013James R SingerMajor ShareholderSell200,000$1.23$246,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/9/2013James R SingerMajor ShareholderSell200,000$1.22$244,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/4/2013James Singermajor shareholderSell466,000$1.24$577,840.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/30/2013James Singermajor shareholderSell84,000$1.31$110,040.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/29/2013James Singermajor shareholderSell150,000$1.30$195,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/28/2013James Singermajor shareholderSell200,000$1.31$262,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/26/2013Anthony Alan RamosCAOBuy25,000$0.01$250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/23/2013Robert C MertonDirectorBuy5,953$0.01$59.53View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/11/2013Alain P Phd RollandVPBuy22,092$0.01$220.92View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/11/2013Jill Marie BroadfootCFOBuy27,060$0.01$270.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/11/2013Vijay B SamantCEOBuy84,600$0.01$846.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/15/2012George J MorrowDirectorBuy6,394$0.01$63.94View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/24/2012James R SingerMajor ShareholderBuy154,333$3.99$615,788.67View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/31/2012James R SingerMajor ShareholderBuy310,000$3.51$1,088,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Vical (NASDAQ:VICL)
DateHeadline
07/25/16 06:45 AMLeading, Losing Stocks in Manufacturing Sector Pre Market
07/13/16 07:27 PMReasons for Lawrence Smith's Shares Sale of Vical Incorporated (NASDAQ:VICL)'s Stock - Press Telegraph
07/12/16 11:29 AMHere is What Institutional Investors Think About Vical Inc (NASDAQ:VICL) - Consumer Eagle
06/30/16 09:49 AMNew Study: Vical Incorporated (VICL) - Financial and Strategic SWOT Analysis Review
06/27/16 06:31 AMNext Weeks Broker Price Targets For Vical Incorporated (VICL) - Fiscal Standard
06/24/16 07:06 PMVical Incorporated (VICL) Current Analyst Ratings - Fiscal Standard
06/21/16 09:12 AMVical (VICL) Reports Phase I/II Data on Genital Herpes Vaccine -
06/21/16 06:22 AMThis Weeks Broker Views For Vical Incorporated (VICL) - Fiscal Standard
06/20/16 10:39 AMVical’s Phase 1/2 Trial Data Presented at ASM 2016 Shows Bivalent Vaccine Imparts Reduction in Genital Herpes Lesions Durable to 9 Months - [at noodls] - Vical plans to advance the bivalent vaccine to a Phase 2 trial in 2016 and maintains current financial guidance for 2016 SAN DIEGO, June 20, 2016 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) presented ...
06/13/16 05:49 AMVical to Present HSV-2 Phase 1/2 Data at June ASM Microbe/ICAAC 2016 Conference - [at noodls] - SAN DIEGO, June 13, 2016 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) announced today that the company will present clinical data on its completed HSV-2 Phase 1/2 trial at the American Society ...
06/07/16 07:24 PMLyons Gary A, Director of Vical Incorporated (NASDAQ:VICL) buys 7,078 shares
06/02/16 10:25 AMVical (VICL) Plans Presentation of VL-2397 Data at BIO International Convention - Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here. Vical Incorporated (Nasdaq: VICL) announced that the company will present an update on its investigational antifungal product candidate, VL-2397, at the BIO ...
05/31/16 05:42 AMVical Provides VL-2397 Updates at BIO International Convention - [at noodls] - SAN DIEGO, May 31, 2016 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) announced today that the company will present an update on its investigational antifungal product candidate, VL-2397, at the ...
05/27/16 10:16 AM5 Gainers And Losers In The Pre-Market Today - Gainers Vical Incorporated (NASDAQ: VICL) is up 873.68 percent after filing to issue more shares of stock and on positive sentiment around the company, which has grown dramatically. Relypsa Inc (NASDAQ: RLYP) is up 25.00 percent as FDA rejects AstraZeneca plc (ADR) (NYSE: AZN) potassium-lowering drug; Relypsa now has the market cornered. Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) is up 20.51 percent as sentiment has turned positive following FDA approval of ...Full story available on Benzinga.com
05/25/16 08:01 AMVICAL INC Files SEC form 8-K, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Ch -
05/24/16 01:00 PMBroker Outlook For The Week Ahead Vical Incorporated (VICL) - Share Trading News - Broker Outlook For The Week Ahead Vical Incorporated (VICL)Share Trading NewsVical Incorporated researches and develops biopharmaceutical products based on its deoxyribonucleic acid (DNA) delivery technologies for the prevention and treatment of life-threatening diseases. The Company has approximately four active, independent, ...
05/24/16 01:00 PMHealthcare Movers to Observe: Grifols, S.A. (NASDAQ:GRFS) , Vical Incorporated (NASDAQ:VICL) - Is stories - Healthcare Movers to Observe: Grifols, S.A. (NASDAQ:GRFS) , Vical Incorporated (NASDAQ:VICL)Is storiesIn most recently trading session on 5/23/2016, Vical Incorporated (NASDAQ:VICL) climbed +8.03% while traded on 1.01 million shares versus it's an average volume of 387.32 thousand shares. The company recorded the last trade with the price of $0.39.and more »
05/20/16 12:47 PMTraders Spotlight: Vical Incorporated (NASDAQ:VICL) , Amedica Corporation (NASDAQ:AMDA) - Street Updates - Traders Spotlight: Vical Incorporated (NASDAQ:VICL) , Amedica Corporation (NASDAQ:AMDA)Street UpdatesVical Incorporated (NASDAQ:VICL) diminished -4.88%, closing at $0.37 after floating between $0.36 and $0.40. The company has market capitalization of $34.05M. It has twelve month low of $0.28 and twelve month high of $1.55. The recent traded volume of ...Stocks Swings: Gilead Sciences (NASDAQ:GILD), TRC Companies (NYSE:TRR), USANA Health Sciences (NYSE ...Benchmark Monitorall 2 news articles »
05/18/16 01:00 PMVical, Inc. :VICL-US: Earnings Analysis: Q1, 2016 By the Numbers -
05/17/16 01:20 PMBuy Recommendations Count For Vical Incorporated (NASDAQ:VICL) At 0 - Stocks Daily - Buy Recommendations Count For Vical Incorporated (NASDAQ:VICL) At 0Stocks DailyZacks rating methodology assigns scores to companies on a simplified 1-5 scale. A score towards the 1-2 band indicates a Buy call, 3 score implies a Hold while a rating of 4 or 5 denotes Sell call. Each brokerage group has its own way of assigning ...and more »
05/17/16 01:20 PMNext Weeks Broker Price Targets For Vical Incorporated (VICL) - Share Trading News - Next Weeks Broker Price Targets For Vical Incorporated (VICL)Share Trading NewsThe stock's market capitalization is 36.65M, it has a 52-week low of 0.28 and a 52-week high of 1.55. The share price of the company (VICL) was down -0.30%, with a high of 0.41 during the day and the volume of Vical Incorporated shares traded was 136312.
05/17/16 01:20 PMRevenue Update on Vical Incorporated(NASDAQ:VICL) - Trade Calls - Revenue Update on Vical Incorporated(NASDAQ:VICL)Trade CallsVical Incorporated(NASDAQ:VICL) announced the earnings results for Fiscal Year 2016 and Q1. The results came in during Pre-market on May 9, 2016. Company reported revenue of $4.60M. Analysts estimated a revenue of $6.88M. Earnings per share were ...
05/12/16 07:06 AMEarnings per Share Report: Vical Incorporated (NASDAQ:VICL) - News Oracle - News OracleEarnings per Share Report: Vical Incorporated (NASDAQ:VICL)News OracleLast Trade: The Company rose 1.56% and finished at $0.39. The daily volume was measured at 2.35 million shares. The 52-week high of the share price is $1.55 and the 52-week low is $0.28. The company has a market cap of $3.09 million. Its latest closing ...and more »
05/12/16 07:06 AMEarnings in Focus: Vical Incorporated (NASDAQ:VICL) - News Oracle - News OracleEarnings in Focus: Vical Incorporated (NASDAQ:VICL)News OracleLast Trade: The Company rose 5.12% and finished at $0.407. The daily volume was measured at 1.57 million shares. The 52-week high of the share price is $1.55 and the 52-week low is $0.28. The company has a market cap of $38.02 million. Its latest ...Analyst Review: Vical Incorporated (VICL)Risers & Fallersall 2 news articles »
05/11/16 06:22 AMAfter Last Week What Do Analysts Think Of Vical Incorporated (VICL) - Share Trading News - News OracleAfter Last Week What Do Analysts Think Of Vical Incorporated (VICL)Share Trading News05/12/2015 – Vical Incorporated was upgraded to “buy” by analysts at Zacks. They now have a USD 1 price target on the stock. The share price of Vical Incorporated (VICL) was up +3.65% during the last trading session, with a day high of 0.40. 10354 ...Earnings Trend per share for Investors: Vical Incorporated (NASDAQ:VICL)News Oracle2 Sizzling Hot Biotechnology Stocks: Vical (NASDAQ:VICL), ACADIA Pharmaceuticals (NASDAQ:ACAD)ZergwatchBiotechnology Unusual Volume: BIND Therapeutics, Inc. (NASDAQ:BIND), Minerva Neurosciences, Inc. (NASDAQ ...KC Registerall 4 news articles »
05/10/16 06:43 AMVical's (VICL) CEO Vijay Samant on Q1 2016 Results - Earnings Call Transcript - Please standby, we are about to begin. Good day, and welcome ladies and gentlemen to the Vical Incorporated Financial Results Conference Call. At this time, I would like to inform you that this conference is being recorded, and then all participants are in ...
05/09/16 06:07 AMQ1 2016 Vical Inc Earnings Release - Before Market Open -
05/09/16 05:56 AMVical Reports First Quarter 2016 Financial Results - [at noodls] - ASP0113 Phase 3 Trial Enrollment Over 80% Complete HSV-2 Data to be presented at June ASM Microbe/ICAAC 2016 Conference SAN DIEGO, May 09, 2016 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today ...
05/09/16 05:36 AMVical reports 1Q loss -
05/06/16 03:05 PMInvestor Calendar Invites You to the Vical First Quarter 2016 Earnings Webcast Live on Monday, May 9, 2016 - [Accesswire] - SAN DIEGO, CA / ACCESSWIRE / May 6, 2016 / Vical Incorporated (NASDAQ: VICL) will host a live webcast to discuss the results of the first quarter 2016, to be held Monday, May 9, 2016 at 12:00 PM Eastern ...
05/06/16 06:51 AMVical Incorporated (VICL) Updated Broker Price Targets - Share Trading News - Vical Incorporated (VICL) Updated Broker Price TargetsShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of Vical Incorporated (VICL). The latest reports which are currently in issue on Thursday 5th of May state 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 ...
05/02/16 05:50 AMVical Announces News Release and Conference Call Schedule for First Quarter 2016 Financial Results - [at noodls] - SAN DIEGO, May 02, 2016 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced that the company will report financial results for the three months ended March 31, 2016, before the opening ...
04/29/16 07:14 AMBroker Roundup For Vical Incorporated (VICL) - Share Trading News - Broker Roundup For Vical Incorporated (VICL)Share Trading News05/12/2015 – Vical Incorporated was upgraded to “buy” by analysts at Zacks. They now have a USD 1 price target on the stock. The share price of Vical Incorporated (VICL) was unchanged +0.00% during the last trading session, with a day high of 0.00.
04/22/16 07:33 AMLatest Analyst Ratings For Vical Incorporated (VICL) - Share Trading News - Latest Analyst Ratings For Vical Incorporated (VICL)Share Trading NewsThe stock's market capitalization is 37.09M, it has a 52-week low of 0.28 and a 52-week high of 1.55. The share price of the company (VICL) was down -1.15%, with a high of 0.41 during the day and the volume of Vical Incorporated shares traded was 20514.and more »
04/20/16 08:06 AMVical Incorporated (NASDAQ:VICL) Reported Comprehensive Income Of $0.04 - Investor Newswire - Vical Incorporated (NASDAQ:VICL) Reported Comprehensive Income Of $0.04Investor NewswireVical Incorporated (NASDAQ:VICL) concluded the year ended 2015–1-2-31 with deferred revenue (current) of $0.25 millions. On quarterly basis, the firm;s deferred revenue (current) for the quarter closed 2015–1-2-31 stood at $0.25 millions. On non ...
04/12/16 10:47 AMCan Shares Of Vical Incorporated (NASDAQ:VICL) Hit $2.5? - Investor Newswire - Can Shares Of Vical Incorporated (NASDAQ:VICL) Hit $2.5?Investor NewswireVical Incorporated (NASDAQ:VICL) has a total of 1 Strong Buy advice and 0 Strong Sell calls as of 2016-04-12. One month earlier, the total count of strong buy recommendations was 1 and strong sell was 0. The mean analyst rating was 2. A month earlier ...and more »
04/12/16 10:47 AMVical Incorporated (NASDAQ:VICL) ABR At 2 - Investor Newswire - Vical Incorporated (NASDAQ:VICL) ABR At 2Investor NewswireBrokerages maintain a strong outlook on Vical Incorporated (NASDAQ:VICL) shares. Based on the Zacks poll results, as of 2016-04-12, the stock has an ABR of 2 rating. This number highlights the scoring on a 1 to 5 scale, where 1 implies Strong Buy and 5 ...and more »
04/12/16 10:47 AMVical Incorporated (NASDAQ:VICL)'s 52-Week Price Target At $2.5000 - Investor Newswire - Vical Incorporated (NASDAQ:VICL)'s 52-Week Price Target At $2.5000Investor NewswireThomson Reuters completed its industry survey and following that it has given a 52-week price estimate of $2.5000 to Vical Incorporated (NASDAQ:VICL) stock. It is the average of the price estimates given by the brokerages during First Call survey. Last ...and more »
04/12/16 10:47 AMVical Incorporated (NASDAQ:VICL) 50-Day Moving Average At $0.3840 - Investor Newswire - Vical Incorporated (NASDAQ:VICL) 50-Day Moving Average At $0.3840Investor NewswireThe technical analysis of Vical Incorporated (NASDAQ:VICL) stock highlights that it is trading $-0.0042 points away -1.0938% from its 50-day MA of $0.3840. Further it is trading $-0.0133 or -3.3804% away its 200-day MA of $0.3931. After considering the ...
04/11/16 01:35 PMVical Incorporated (NASDAQ:VICL) Short Interest Decreased By 38.79% - RiversideGazette.com - Vical Incorporated (NASDAQ:VICL) Short Interest Decreased By 38.79%RiversideGazette.comThe stock of Vical Incorporated (NASDAQ:VICL) registered a decrease of 38.79% in short interest. VICL's total short interest was 415,400 shares in April as published by FINRA. Its down 38.79% from 678,700 shares, reported previously. With 409,000 ...
04/11/16 01:35 PMAnalysts gives Consensus Recommendation of “Buy” to Vical Incorporated (NASDAQ:VICL) - Washington News Wire - Washington News WireAnalysts gives Consensus Recommendation of “Buy” to Vical Incorporated (NASDAQ:VICL)Washington News WireVical logo Vical Incorporated (NASDAQ:VICL) has been given a consensus broker rating score of 2.00 (Buy) from the two brokers that provide coverage for the stock, Zacks Investment Research reports. One research analyst has rated the stock with a hold ...Vical Incorporated (NASDAQ:VICL) Given Consensus Recommendation of "Buy" by AnalystsWeb Breaking Newsall 3 news articles »
04/09/16 09:54 AMVical Inc (NASDAQ:VICL) Sentiment Report - RiversideGazette.com - Vical Inc (NASDAQ:VICL) Sentiment ReportRiversideGazette.comVical Inc (NASDAQ:VICL) institutional sentiment decreased to 0.48 in 2015 Q3. Its down -0.19, from 0.67 in 2015Q2. The ratio dived, as 18 funds increased or started new stock positions, while 27 sold and reduced stakes in Vical Inc. The funds in our ...Analyst Review: Vical Incorporated (VICL)Risers & FallersVical Incorporated (VICL) Updated Broker Price TargetsShare Trading Newsall 3 news articles »
04/08/16 10:38 AMRa Capital Management Exits Position in Vical Incorporated (VICL) - Everything HUDSON - Ra Capital Management Exits Position in Vical Incorporated (VICL)Everything HUDSONVical Incorporated (VICL) : Ra Capital Management has sold out all of its stake in Vical Incorporated during the Q4 period, according to the information disclosed to the SEC. The investment management company has sold out 2,084,078 shares of Vical ...
04/05/16 12:06 PMCan Shares Of Vical Incorporated (NASDAQ:VICL) Touch $2.5? - Stocks Daily - Can Shares Of Vical Incorporated (NASDAQ:VICL) Touch $2.5?Stocks DailyAs per Zacks Research report, the stock of Vical Incorporated (NASDAQ:VICL) have been placed the high price target of $2.5. The brokerages have the price estimate fixed at $ 2.5. This indicates the expert opinion of 1 brokerages that have assigned the ...and more »
04/05/16 12:06 PMVical Incorporated (NASDAQ:VICL) Short Interest Decreased By 38.79% - Business Standard Tribune - Vical Incorporated (NASDAQ:VICL) Short Interest Decreased By 38.79%Business Standard TribuneThe stock of Vical Incorporated (NASDAQ:VICL) registered a decrease of 38.79% in short interest. VICL's total short interest was 415,400 shares in April as published by FINRA. Its down 38.79% from 678,700 shares, reported previously. With 409,000 ...and more »
04/03/16 12:17 PMVical Incorporated (VICL) Broker Price Targets For The Coming Week - Share Trading News - Vical Incorporated (VICL) Broker Price Targets For The Coming WeekShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of Vical Incorporated (VICL). The latest reports which are currently in issue on Sunday 3rd of April state 0 analysts have a rating of “strong buy”, 1 analysts “buy”, 1 ...
03/31/16 01:00 PMTrader's Buzzers: Vical Incorporated (VICL), ACADIA Pharmaceuticals Inc. (ACAD) - News Oracle - News OracleTrader's Buzzers: Vical Incorporated (VICL), ACADIA Pharmaceuticals Inc. (ACAD)News OracleThe company's RSI reading has hit 67.97. The stock edged higher by 9.24% to close previous trading session at USD 26.01. The shares of the company fluctuated in the range of USD 16.64 and USD 51.99 in the course of 52 weeks. Over the three months, ...5 Stocks Under Wall Street's Radar: ACADIA Pharmaceuticals (NASDAQ:ACAD), State Street Corporation (NYSE:STT ...Benchmark Monitorall 9 news articles »
03/31/16 01:00 PMVical Incorporated (VICL) Analyst Review - Risers & Fallers - The Vista VoiceVical Incorporated (VICL) Analyst ReviewRisers & FallersA number of investment brokers have recently updated their price targets on shares of Vical Incorporated (VICL). According to the latest broker reports outstanding on Thursday 31st of March, 0 analysts have a rating of “strong buy”, 1 analysts “buy”, 1 ...Vical Incorporated (VICL) Short Interest UpdateThe Vista VoiceShining on Major News: Yahoo! Inc. (NASDAQ:YHOO), Vical Incorporated (NASDAQ:VICL), Galmed Pharmaceuticals ...Benchmark Monitorall 3 news articles »
03/30/16 11:58 AMShort Interest in Vical Incorporated (VICL) Decreases By 38.8% - MicroCap Magazine - MicroCap MagazineShort Interest in Vical Incorporated (VICL) Decreases By 38.8%MicroCap MagazineVical logo Vical Incorporated (NASDAQ:VICL) saw a significant decline in short interest during the month of March. As of March 15th, there was short interest totalling 415,443 shares, a decline of 38.8% from the February 29th total of 678,702 shares, ...and more »
03/30/16 11:58 AMMost Active Stocks to Move: Linn Energy LLC (LINE), Vical Incorporated (VICL) - News Oracle - Most Active Stocks to Move: Linn Energy LLC (LINE), Vical Incorporated (VICL)News OracleThe Company moved 8.61% up right now and is at $0.391. Stock is trading in the real-time trading session with the total volume of 5.28 million shares, as compared to its average volume of 13.52 million shares. The 52-week range of the share price is ...

Social

About Vical

Vical logoVical Incorporated researches and develops biopharmaceutical products based on its deoxyribonucleic acid (DNA) delivery technologies for the prevention and treatment of life-threatening diseases. The Company has approximately four active, independent, or partnered development programs in the areas of infectious disease including Phase III clinical trial of ASP0113 for prevention of cytomegalovirus (CMV) reactivation in stem cell transplant recipients and Phase II clinical trial of ASP0113 for prevention of CMV infection in kidney transplant recipients; Phase I/II clinical trial of its therapeutic genital herpes vaccine, designed to reduce viral shedding and genital herpes lesions in herpes simplex virus type 2 (HSV-2) infected patients; an ongoing Phase I program of VL-2397 for invasive fungal infections, and completed preclinical program, with an allowed investigational new drug application (IND) using its CyMVectin prophylactic vaccine formulated with its Vaxfectin adjuvant.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: VICL
  • CUSIP: 92560210
Key Metrics:
  • Previous Close: $4.38
  • 50 Day Moving Average: $4.43
  • 200 Day Moving Average: $3.93
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $37.08M
  • Beta: 2.03
  • Current Year EPS Consensus Estimate: $-1 EPS
  • Next Year EPS Consensus Estimate: $-0.2 EPS
Additional Links:
Vical (NASDAQ:VICL) Chart for Monday, July, 25, 2016